Analysts' Actions: AMTD, BA, FB, PCG, M
Itron (ITRI) estimates, target cut at JP Morgan. Shares of ITRI now seen reaching $48, according to JP Morgan. Estimates also reduced, given higher macro uncertainty. Overweight rating.
Macy's (M) removed from Top Picks Live! at Citigroup. Strong outperformance and SSS comps are challenging. Maintain $49 price target and Buy rating.
Manpower (MAN) estimates, target cut at BofA/Merrill. Shares of MAN now seen reaching $40. Estimates also reduced, given slower European activity. Neutral rating.
Mattel (MAT) estimates reduced at Wells through 2013, Wells Fargo said. Company is leveraged to a stronger dollar. Outperform rating.
Medivation (MDVN) target raised at Jefferies. Shares of MDVN now seen reaching $105. Zytiga pre-chemo survival data bode well for Enzalutamide's prospect. Buy rating. Medivation estimates, target raised at Credit Suisse. Shares of MDVN now seen reaching $122, according to Deutsche Bank. Estimates also increased, as new pre-chemo data looks impressive. Outperform rating. Monsanto (MON) estimates, target boosted at BofA/Merrill. Shares of MON now seen reaching $96, according to Bank of America/Merrill Lynch. Company should see higher domestic corn and soybean demand. Buy rating. OGE Energy (OGE) numbers raised at Jefferies. Shares of OGE now seen reaching $57, Jefferies said. Estimates also raised on interim rate increase. Hold rating. Skyworks (SWKS) estimates upped at JMP through 2013, JMP Securities said. Channel checks suggest higher growth. Outperform rating and $40 price target. Trimble (TRMB) estimates, target cut at JP Morgan. Shares of TRMB now seen reaching $55, according to JP Morgan. Estimates also reduced, given macro uncertainty. Overweight rating. Wal-Mart (WMT) estimates increased at Morgan Stanley through 2015, Morgan Stanley said. Company has solid operating leverage. Equal-weight rating. >To submit a news tip, email: tips@thestreet.com.Follow TheStreet on Twitter and become a fan on Facebook.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
